Stephania hainanensis
Stephania hainanensis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Stephania hainanensis is a unique botanical species that has garnered significant interest within the field of pharmacological research. Scientists have identified specific bioactive compounds within the plant, most notably the alkaloid oxocrebanine. This chemical constituent is currently being studied for its potential therapeutic properties in medicinal applications. Research is particularly focused on how these derivatives might influence the progression of hepatocellular carcinoma. As studies continue, this plant may offer valuable insights into developing new strategies for managing liver cancer.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Menispermaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Stephania hainanensis is a distinctive species known locally by its common name, 海南地不容. This plant holds a unique place within its native ecosystem, forming intricate connections with the surrounding flora and fauna. By studying its biological interactions, researchers can better understand the delicate balance of its natural habitat. These relationships highlight the complex web of life that supports the survival of such specialized vegetation. Ultimately, recognizing both its scientific and local identity helps foster a deeper appreciation for its role in the environment.
Sources: Catalogue of Life (COL)
Taxonomy
Stephania hainanensis is a distinctive member of the kingdom Plantae that plays a unique role in its ecosystem. As a species belonging to the genus Stephania, it displays specialized morphological traits characteristic of its lineage. This plant is further classified within the order Ranunculales, connecting it to a broad group of flowering plants. It falls under the family Menispermaceae, a group known for various medicinal and climbing properties. Finally, its biological placement within the class Equisetopsida solidifies its position within the complex hierarchy of the plant world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Ranunculales |
| Family | Menispermaceae |
| Genus | Stephania |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Stephania hainanensis is a distinct botanical species primarily found within the Asia-temperate region. Its specific geographic presence is concentrated in China, where it thrives in unique local ecosystems. Within this territory, the island of Hainan serves as a vital stronghold for its natural development. Understanding its precise distribution helps researchers better comprehend the environmental needs of this particular plant. Consequently, the preservation of its native Chinese habitats remains essential for the continued survival of the species.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Biological Activities
Compounds
Stephania hainanensis is a traditional Chinese medicinal plant that serves as a vital source of bioactive compounds. One significant alkaloid isolated from this species is oxocrebanine, which has demonstrated potent anti-tumor properties. Research indicates that oxocrebanine effectively inhibits the proliferation of human hepatocellular carcinoma cells through the promotion of apoptosis and autophagy. These effects have been observed both in vitro using Hep3B2.1-7 cell lines and in vivo using nude mouse models. Ultimately, the study highlights the therapeutic potential of oxocrebanine as a lead compound for treating liver cancer.
Conditions
Stephania hainanensis provides a source of oxocrebanine, a compound that effectively treats hepatocellular carcinoma. Research indicates that this substance inhibits the proliferation of human Hep3B2.1-7 cells by promoting both apoptosis and autophagy. In laboratory settings, oxocrebanine works by upregulating specific pro-apoptotic proteins and modulating the PI3K/Akt/mTOR pathway. These anti-tumor effects were further validated through in vivo experiments using nude mouse models. Ultimately, the plant-derived compound demonstrates significant potential in suppressing liver cancer growth through these dual biological mechanisms.